Funded Startups in Saint Laurent
Across the 5 most recent funded entries tied to Saint Laurent (Quebec, Canada), e2ip technologies’ $120M Series B round on 2023-04-26 is a clear outlier: i…
Across the 5 most recent funded entries tied to Saint Laurent (Quebec, Canada), e2ip technologies’ $120M Series B round on 2023-04-26 is a clear outlier: it sits well above the rest of the disclosed amounts ($10M for Reaction Dynamics on 2025-06-18; $3M for IntelGenX on 2023-01-09; $2M for Optina Diagnostics on 2022-01-24), with only Reaction Dynamics breaking into double-digit disclosed funding. The list also clusters by sector and time: 3 of the 5 entries are in Biotechnology (IntelGenX 2023-01-09 $3M; Optina Diagnostics 2022-01-24 $2M; e2ip technologies 2023-04-26 $120M), and 3 rounds fall between 2023-01-09 and 2023-04-26 (IntelGenX, e2ip technologies, and Azzera is also 2023-08-31 though amount is undisclosed). The newest entry is Reaction Dynamics on 2025-06-18 ($10M), while the oldest disclosed-date entry is Optina Diagnostics on 2022-01-24 ($2M).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Saint Laurent here, and how does it compare to the other disclosed amounts?
e2ip technologies’ $120M (Series B, 2023-04-26) is the only disclosed round above $100M, far exceeding the next-largest disclosed amount of $10M (Reaction Dynamics, 2025-06-18). The remaining disclosed amounts are $3M (IntelGenX, 2023-01-09) and $2M (Optina Diagnostics, 2022-01-24).
Do these 5 entries cluster in time, or are they spread out evenly?
They’re somewhat clustered around early-to-mid 2023: 3 entries have round dates between 2023-01-09 and 2023-04-26 (IntelGenX on 2023-01-09; e2ip technologies on 2023-04-26; and Azzera’s 2023-08-31 is later but still within the 2023 window). The span also stretches from 2022-01-24 (Optina Diagnostics) to 2025-06-18 (Reaction Dynamics).
Is any sector over-represented in this Saint Laurent slice?
Biotechnology appears 3 times out of 5 entries (IntelGenX $3M on 2023-01-09; Optina Diagnostics $2M on 2022-01-24; e2ip technologies $120M on 2023-04-26). The other two sectors are Transportation (Reaction Dynamics, $10M, 2025-06-18) and Information Technology (Azzera, undisclosed, 2023-08-31) plus Consumer Electronics for e2ip technologies’ label in the row is Consumer Electronics—so sector clustering is best reflected by the explicit Biotechnology rows.
How much of the stage information is missing or non-standard in these recent rounds?
Two entries do not provide a standard disclosed amount at all: Azzera is marked “undisclosed” (Seed, 2023-08-31), while IntelGenX is listed as “Series Unknown” with a disclosed $3M (2023-01-09) and Optina Diagnostics is “Venture - Series Unknown” with $2M (2022-01-24). Overall, 3 of 5 entries include “Series Unknown”-style labels or undisclosed amounts (IntelGenX, Optina Diagnostics, and Azzera).
Which entries are most recent within the rows shown, and what stage/amount patterns appear at the top?
Only one entry lands in 2025 among the 5 rows: Reaction Dynamics on 2025-06-18 at $10M (Series A). The rest of the disclosed amounts cluster in 2022–2023 (Optina Diagnostics $2M on 2022-01-24; IntelGenX $3M on 2023-01-09; e2ip technologies $120M on 2023-04-26; and Azzera in 2023-08-31 with undisclosed funding).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.